Core Scientific (CORZ) Payables (2021 - 2026)

Core Scientific (CORZ) has 6 years of Payables data on file, last reported at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Payables rose 4618.34% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (up 4618.34% YoY), and the FY2025 full-year result was $126.1 million, up 254.68% from the prior year.
• Payables grew to $1.1 billion in Q1 2026, from $126.1 million in the prior quarter.
• In the past five years, Payables ranged from a high of $1.1 billion in Q1 2026 to a low of $22.5 million in Q1 2025.
• A 5-year average of $210.5 million and a median of $86.0 million in 2023 frame the typical range for Payables.
• Across the five-year window, Payables surged 6179.44% in 2022 and plunged 87.26% in 2024, its largest moves.
• Tracing CORZ's Payables over 5 years: stood at $89.9 million in 2022, then jumped by 210.52% to $279.1 million in 2023, then sank by 87.26% to $35.6 million in 2024, then soared by 254.68% to $126.1 million in 2025, then jumped by 743.42% to $1.1 billion in 2026.
• Business Quant data shows CORZ's Payables at $1.1 billion in Q1 2026, $126.1 million in Q4 2025, and $212.2 million in Q3 2025.